Cancer Test Trials: EU Screening Plan Envisions Proxy Endpoint Recognition
This article was originally published in The Gray Sheet
Executive Summary
The European Commission is considering adding further diagnostic cancer screens to the testing it supports in a recently announced call for member states to establish early detection programs
You may also be interested in...
Routine Mammography Not Vital For Women In Their 40’s – NEJM Study
The risks of routine mammography screening for breast cancer detection among women ages 40-49 may outweigh the potential benefits, according to a study in the April 24 New England Journal of Medicine.
USPSTF Drops Opposition To Prostate Screening, Remains Skeptical
The U.S. Preventive Services Task Force will no longer recommend against routine prostate cancer screening, but cautions that the benefits have not been fully demonstrated
‘Clear’ Is In The Eye Of The Beholder, New York, CRN Argue In Age-Restricted Sales Litigation
CRN’s request for clarification, as it continues litigating complaint in US District Court for Southern New York, highlights what it contends is vague and overly general language in the legislation passed in October with a 22 April effective date.